Viridian Therapeutics, Inc.\DE (VRDN) Other Gross PP&E Adjustments: 2014-2025
Historic Other Gross PP&E Adjustments for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Sep 2025 value amounting to -$2.6 million.
- Viridian Therapeutics, Inc.\DE's Other Gross PP&E Adjustments fell 416.40% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.1 million, marking a year-over-year increase of 20.88%. This contributed to the annual value of -$7.4 million for FY2024, which is 46.93% up from last year.
- Latest data reveals that Viridian Therapeutics, Inc.\DE reported Other Gross PP&E Adjustments of -$2.6 million as of Q3 2025, which was down 30.60% from -$2.0 million recorded in Q2 2025.
- Viridian Therapeutics, Inc.\DE's Other Gross PP&E Adjustments' 5-year high stood at $654,000 during Q3 2021, with a 5-year trough of -$14.0 million in Q4 2023.
- For the 3-year period, Viridian Therapeutics, Inc.\DE's Other Gross PP&E Adjustments averaged around -$3.4 million, with its median value being -$2.0 million (2025).
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first slumped by 592.97% in 2022, then soared by 73.05% in 2024.
- Viridian Therapeutics, Inc.\DE's Other Gross PP&E Adjustments (Quarterly) stood at -$2.7 million in 2021, then rose by 7.96% to -$2.4 million in 2022, then slumped by 471.98% to -$14.0 million in 2023, then surged by 46.93% to -$7.4 million in 2024, then crashed by 416.40% to -$2.6 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$2.6 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$2.1 million for Q1 2025.